Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-1-8

Curated date: 2023/10/13

Curator: MyleeeA

Revision editor(s): MyleeeA, Folakunmi

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to antiviral drug Response to antiviral drug,response to antiviral drug
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Baseline samples
Group 1 name Corresponds to the case (exposed) group for case-control studies
Week 24 samples
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Saliva samples after 24 weeks of antiretroviral therapy
Group 0 sample size Number of subjects in the control (unexposed) group
35
Group 1 sample size Number of subjects in the case (exposed) group
35
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
N/A

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-1-8

Curated date: 2023/10/16

Curator: MyleeeA

Revision editor(s): MyleeeA

Source: Figure 2 :Table S1

Description: Bacterial taxa differentially abundant in saliva prior to and following 24 weeks of antiretroviral therapy

Abundance in Group 1: increased abundance in Week 24 samples

NCBI Quality ControlLinks
Treponema lecithinolyticum

Revision editor(s): MyleeeA

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-1-8

Curated date: 2023/10/16

Curator: MyleeeA

Revision editor(s): MyleeeA, Folakunmi

Source: Figure 2, Table S1

Description: Bacterial taxa differentially abundant in saliva prior to and following 24 weeks of antiretroviral therapy

Abundance in Group 1: decreased abundance in Week 24 samples

NCBI Quality ControlLinks
Muribaculum intestinale

Revision editor(s): MyleeeA, Folakunmi